Back to search

O-59 Quality of life with single agent oral topotecan vs intravenous topotecan in patients with chemosensitive small cell lung cancer (SCLC). An international phase III study

Richard J. Graila, John R. Eckardt, Joachim von Pawel, Kelly M. Grotzinger, Graham Ross
DOI: 10.1016/s0169-5002(03)91717-x
Lung Cancer

Data up to Jan 2025

Published2003
Citations7
References0
Fields
MedicineOncologyInternal medicineNursing

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

O-59 Quality of life with single agent oral topotecan vs intravenous topotecan in… (2003) – Lung Cancer | Metascience Observatory Explorer